Wealthcare Advisory Partners LLC Sells 223 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Wealthcare Advisory Partners LLC trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,133 shares of the healthcare conglomerate’s stock after selling 223 shares during the period. Wealthcare Advisory Partners LLC’s holdings in UnitedHealth Group were worth $2,597,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of UNH. Procyon Advisors LLC raised its holdings in shares of UnitedHealth Group by 13.3% during the fourth quarter. Procyon Advisors LLC now owns 23,701 shares of the healthcare conglomerate’s stock valued at $11,989,000 after acquiring an additional 2,780 shares in the last quarter. Border to Coast Pensions Partnership Ltd raised its holdings in UnitedHealth Group by 13.3% in the 4th quarter. Border to Coast Pensions Partnership Ltd now owns 160,002 shares of the healthcare conglomerate’s stock worth $80,885,000 after purchasing an additional 18,737 shares in the last quarter. Tompkins Financial Corp boosted its stake in shares of UnitedHealth Group by 21.3% during the 4th quarter. Tompkins Financial Corp now owns 2,094 shares of the healthcare conglomerate’s stock valued at $1,059,000 after purchasing an additional 367 shares in the last quarter. RDA Financial Network lifted its holdings in UnitedHealth Group by 4.1% in the fourth quarter. RDA Financial Network now owns 8,978 shares of the healthcare conglomerate’s stock worth $4,542,000 after buying an additional 356 shares during the period. Finally, Goldstone Financial Group LLC raised its position in shares of UnitedHealth Group by 21.0% in the 4th quarter. Goldstone Financial Group LLC now owns 1,169 shares of the healthcare conglomerate’s stock worth $591,000 after acquiring an additional 203 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of research reports. TD Cowen increased their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. UBS Group dropped their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Piper Sandler reduced their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. Finally, Truist Financial reduced their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Two analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Buy” and a consensus target price of $627.74.

UnitedHealth Group Price Performance

NYSE UNH opened at $510.03 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The stock has a market capitalization of $469.37 billion, a price-to-earnings ratio of 33.23, a PEG ratio of 1.42 and a beta of 0.62. The business’s fifty day moving average price is $551.50 and its 200-day moving average price is $562.62.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the prior year, the firm earned $5.83 EPS. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. On average, equities analysts predict that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.65%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.